Your browser doesn't support javascript.
loading
ASK1 activation in glial cells in post-mortem multiple sclerosis tissue.
Seki, Erika; Guo, Xiaoli; Namekata, Kazuhiko; Komori, Takashi; Hayashi, Hiroyuki; Arai, Nobutaka; Harada, Takayuki.
Afiliação
  • Seki E; Laboratory of Molecular Pathology and Histology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Guo X; Visual Research Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Namekata K; Visual Research Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Komori T; Department of Laboratory Medicine and Pathology (Neuropathology), Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
  • Hayashi H; Department of Pathology, Yokohama Municipal Citizen's Hospital, Kanagawa, Japan.
  • Arai N; Department of Laboratory Medicine and Pathology (Neuropathology), Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
  • Harada T; Visual Research Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Neuropathology ; 2024 May 22.
Article em En | MEDLINE | ID: mdl-38775061
ABSTRACT
Multiple sclerosis (MS), the leading cause of disability in young adults, is an inflammatory disease of the central nervous system characterized by localized areas of demyelination. Apoptosis signal-regulating kinase 1 (ASK1) is a mitogen-activated protein kinase kinase kinase that has been shown to be implicated in the pathogenesis of experimental autoimmune encephalomyelitis (EAE), a mouse model of MS. Interestingly, ASK1 signaling regulates glial cell interactions and drives neuroinflammation in EAE mice. To further investigate its clinical significance, in the present study, we examined the activation of ASK1 in the post-mortem brain of MS patients. ASK1 activation was found in active lesions of the corpus callosum in both microglia/macrophages and astrocytes. Moreover, ASK1 activation in astrocytes was higher than that in microglia/macrophages, which was in line with our findings in EAE mice. Our results suggest an important role of ASK1 in glial cells, indicating that ASK1 might be a good therapeutic target for MS.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article